Digital Life Line develops proprietary amplification reagents that work on rapid antigen tests to provide enhanced detection sensitivity comparable to lab quality tests, at a fraction of the reaction time and cost. Intended for highly accurate qualitative detection of a wide range of diseases from respiratory, metabolic, gastrointestinal, sexual health to global pandemic response, Digital Life Line has proven development, regulatory and commercial experience to drive next-generation rapid diagnostics that combine the accuracy of PCR with convenience of antigen tests.